ConductScience.org, home

Paper1928065

C1q nephropathy: a pediatric clinicopathologic study.

Iskandar SS and 2 others. Am J Kidney Dis, 1991. Cited by 60 papers, by iCite.

Cite this record

ConductScience Library. C1q nephropathy: a pediatric clinicopathologic study. Papers, record 1928065. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1928065

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
C1q nephropathy: a pediatric clinicopathologic study.
PubMed
Journal
Am J Kidney Dis
PubMed
Year
1991
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
2.5
iCite
Revised in PubMed
2019-08-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iskandar SSS S
2Browning MCM C
3Lorentz WBW B

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement C1qMajor topic
Kidney DiseasesMajor topic
Adolescent
Child
Child, Preschool
Complement C3
Female
Fluorescent Antibody Technique
Humans
Immunoglobulins
Kidney Glomerulus
Male

Source PubMed

Download CSV of topics

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
42930038Primary Mesangial Proliferative Glomerulonephritis: The Forgotten Glomerulopathy.Antibodies (Basel)2026https://conductscience.org/library/papers/42930038PubMed
40950996Hepatic tuberculosis induced by rituximab treatment for C1q nephropathy with minimal change disease: a case report.Front Med (Lausanne)2025https://conductscience.org/library/papers/40950996PubMed
39678627Immunofluorescence Use and Techniques in Glomerular Diseases: A Review.Glomerular Dis2024https://conductscience.org/library/papers/39678627PubMed
35711019A possible role of classical complement pathway activation in the pathogenesis of immunoglobulin G nephropathy: a case report.CEN Case Rep2023https://conductscience.org/library/papers/35711019PubMed
35283565C1q Nephropathy in Children with Nephrotic Syndrome: Treatment Strategies and Outcomes.Indian J Nephrol2022https://conductscience.org/library/papers/35283565PubMed
33634050Case Report: Complete Remission of C1q Nephropathy Treated With a Single Low-Dose Rituximab, a Reality or Coincidence?Front Pediatr2020https://conductscience.org/library/papers/33634050PubMed
31002691C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics.PLoS One2019https://conductscience.org/library/papers/31002691PubMed
29625558Predominant but silent C1q deposits in mesangium on transplanted kidneys - long-term observational study.BMC Nephrol2018https://conductscience.org/library/papers/29625558PubMed
26640759C1q Nephropathy: The Unique Underrecognized Pathological Entity.Anal Cell Pathol (Amst)2015https://conductscience.org/library/papers/26640759PubMed
25984017C1q nephropathy: a true immune complex disease or an immunologic epiphenomenon?NDT Plus2009https://conductscience.org/library/papers/25984017PubMed
25340146C1q nephropathy- unity in diversity.J Renal Inj Prev2013https://conductscience.org/library/papers/25340146PubMed
24326785C1q nephropathy in children: clinical characteristics and outcome.Pediatr Nephrol2014https://conductscience.org/library/papers/24326785PubMed
24282787Diverse clinical and histology presentation in c1q nephropathy.Nephrourol Mon2013https://conductscience.org/library/papers/24282787PubMed
23852271Do C1q or IgM nephropathies predict disease severity in children with minimal change nephrotic syndrome?Pediatr Nephrol2014https://conductscience.org/library/papers/23852271PubMed
23087557Non-nephronal hematuria misdiagnosed as C1q nephropathy: Look before you leap.Indian J Nephrol2012https://conductscience.org/library/papers/23087557PubMed
21107633Resolution of clinical and pathologic features of C1q nephropathy after rituximab therapy.Clin Exp Nephrol2011https://conductscience.org/library/papers/21107633PubMed
20180137C1q nephropathy in the pediatric population: pathology and pathogenesis.Pediatr Nephrol2010https://conductscience.org/library/papers/20180137PubMed
20116156Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report.Am J Kidney Dis2010https://conductscience.org/library/papers/20116156PubMed
19669167C1q nephropathy in a child presenting with recurrent gross hematuria.Pediatr Nephrol2010https://conductscience.org/library/papers/19669167PubMed
19373520Current status and issues of C1q nephropathy.Clin Exp Nephrol2009https://conductscience.org/library/papers/19373520PubMed

See all 35 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C1QA712PubTator's text mininghttps://conductscience.org/library/genes/712NCBI Gene
C3718PubTator's text mininghttps://conductscience.org/library/genes/718NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1928065

GET https://conductscience.org/api/papers/v1/1928065/cited_by?page=2